Navigation Links
China Medicine Announces Conference Call to Discuss First Quarter 2010 Results

GUANGZHOU, China, May 10 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) is a developer, manufacturer and leading distributor in China of Western pharmaceuticals, traditional Chinese medicine products, other nutraceuticals, medical devices, and medical formulations, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Thursday, May 13, 2010 to discuss its first quarter 2010 results.

Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of China Medicine Corporation, will be Mr. Fred Cheung, Chief Financial Officer. The Company plans to issues its earnings release prior to the call.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 1-800-688-0796. International callers should dial 1-617-614-4070, Conference Passcode: 10924041.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Thursday, May 13, at 11:00 p.m. Eastern Time. To access the replay, dial 1-888-286-8010, international callers dial 1-617-801-6888, and enter the passcode of 97174060.

About China Medicine Corporation

China Medicine Corporation, a comprehensive enterprise with a research and development centre, manufacturing facilities and well established sales network, engages in the production and distribution of prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company distributes its products to wholesale distributors, including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company is developing a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds.

    For more information, please contact:

    Company Contact:
     Gavin Chen
     Assistant to CFO
     China Medicine Corporation
     Tel:   +86-20-8737-2102

    Investor Relations Contact:
     Ms. Lei Huang, Account Manager
     CCG Investor Relations
     Tel:   +1-646-833-3417 (NY Office)

     Mr. Crocker Coulson, President
     CCG Investor Relations
     Tel:   +1-646-213-1915

SOURCE China Medicine Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Sky One Medical Announces Conference Call to Discuss First Quarter 2010 Results
2. Reportlinker Adds Future of Red Biotechnology in China
3. Chinas first open-access journal Nano Research listed in Science Citation Index
4. Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study
5. China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010
6. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
7. China Sky One Medical to Attend Rodman & Renshaw Annual China Investment Conference
8. China Baicaotang to Attend Rodman & Renshaw Annual China Investment Conference
9. China Medical Technologies Reports Third Fiscal Quarter Financial Results
10. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
11. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
Post Your Comments:
(Date:10/9/2017)... ... 2017 , ... At its national board meeting in North Carolina, ARCS® ... Departments of Physics and Astronomy, has been selected for membership in ARCS Alumni ... the 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface ... detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. ... to perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s ...
(Date:10/6/2017)... Boston, Mass. (PRWEB) , ... October 06, 2017 ... ... spotlight female entrepreneurship within the healthcare and technology sector at their fourth annual ... six panels featuring 30 inspiring speakers and the ELEVATE pitch competition showcasing early ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):